製薬用溶剤の世界市場2016-2026

◆英語タイトル:Pharmaceutical Solvent Market: Ether Pharmaceutical Solvent Segment Projected to Register Significant CAGR over the Forecast Period: Global Industry Analysis and Opportunity Assessment, 2016-2026
◆商品コード:FMI703067
◆発行会社(調査会社):Future Market Insights
◆発行日:2017年1月6日
◆ページ数:152
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:化学
◆販売価格オプション(消費税別)
Individual (single user)USD5,000 ⇒換算¥555,000見積依頼/購入/質問フォーム
EnterpriseUSD10,000 ⇒換算¥1,110,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規販売代理店です。Future Market Insights社の概要及び新刊レポートはこちらでご確認いただけます。
本調査レポートでは、製薬用溶剤の世界市場について調査・分析し、製薬用溶剤の世界市場動向、製薬用溶剤の世界市場規模、市場予測、セグメント別製薬用溶剤市場分析、地域別市場規模(北米市場、南米市場、アジア市場、日本市場、ヨーロッパ市場など)、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

Increasing growth of pharmaceutical and health care sectors in developing countries is fuelling the global pharmaceutical solvent market
The global pharmaceutical solvent market is expected to register a CAGR of 4.2% over the assessment period to account for US$ 4.1 Bn by 2026 end.

Global pharmaceutical solvent market analysis by Chemical Group

The Ether Pharmaceutical Solvent segment is projected to register a significant CAGR over the forecast period

The Ether pharmaceutical solvent segment is projected to gain 160 BPS between 2016 and 2026. This segment is estimated to register a CAGR of 5.5% over the forecast period, expected to reach up to US$ 699.2 Mn by the end of 2026

The growing demand for dimethyl ether and polyethylene glycol is expected to boost the demand in the ether pharmaceutical segment

The Others pharmaceutical solvent segment is expected to lose 100 BPS over the projected period

The Others segment is expected to register a CAGR of 4.0% over the forecast period. This segment is expected to reach up to US$ 1,023 Mn by the end of 2026

The Ether pharmaceutical segment is expected to expand in the first half over the forecast period and is expected to have stable growth in the global pharmaceutical solvent market

The Alcohol pharmaceutical solvent segment is expected to account for the maximum share in the global pharmaceutical solvent market, registering an estimated CAGR of 4.5%

The Chlorinated Solvents segment is expected to expand in second half with an estimated CAGR of 3.5% over the forecast period

The Ester pharmaceutical segment is expected to have stable growth in the global pharmaceutical solvent market expanding with an estimated CAGR of 4.0% over the forecast period

The Alcohol pharmaceutical solvent segment is expected to create high value opportunity over the forecast period

The Alcohol pharmaceutical solvent segment is expected to register an estimated CAGR of 4.5% over the forecast period. This segment is expected to create total incremental opportunity of US$ 541 Mn between 2016 and 2026

The Others pharmaceutical solvent segment is expected to create high value opportunity over the forecast period

The Chlorinated Solvents segment is expected to register an estimated CAGR of 3.5% over the forecast period reaching up to US$ 52.3 Mn by the end of 2016. This segment is expected to create total incremental opportunity of US$ 21 Mn between 2016 and 2026

The Others pharmaceutical solvent segment is expected to register an estimated CAGR of 4% over the forecast period, reaching up to US$ 1023 Mn by the end of 2026. This segment is expected to create total incremental opportunity of US$ 334 Mn between 2016 and 2026

The Ester pharmaceutical segment is expected to gain maximum attractiveness over the assessment period

The Ester pharmaceutical solvent segment is expected to gain maximum market attractiveness between 2016 and 2026. This segment is expected to expand with an estimated CAGR of 4.0% over the forecast period, reaching up to US$ 640.6 Mn by the end of 2026

Growing demand for ethyl acetate is expected to fuel the demand of the Ester pharmaceutical solvent segment. Ethyl acetate is expected to register an estimated CAGR of 4.6% over the forecast period

The Ether pharmaceutical solvent segment is expected to gain attractiveness between 2016 and 2026, and is anticipated to hold a market share of 16.7% in the global pharmaceutical solvent market

【レポートの目次】

Table Of Content

1. Executive Summary

2. Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

2.3. Parent / Associated Market Overview

3. Global Analysis Scenario

3.1. Market Volume Analysis

3.1.1. Regional Consumption Outlook

3.2. Pricing Analysis

3.2.1. Pricing Assumptions

3.2.2. Price Projections Per Region

3.3. Market Size (US$ Mn) and Forecast

3.3.1. Market Size and Y-o-Y Growth

3.3.2. Absolute $ Opportunity

3.4. Market Overview

3.4.1. Supply Chain

3.4.2. List of Active Participants

3.4.2.1. Raw material Suppliers

3.4.2.2. Manufacturers

3.4.2.3. Distributors / Retailers

3.4.2.4. End User

4. Market Dynamics

4.1. Macro-economic Factors

4.2. Drivers

4.2.1. Supply Side

4.2.2. Demand Side

4.3. Restraints

5. Global Analysis and Forecasts, By Chemical Group

5.1. Introduction

5.2. Basis Point Share (BPS) Analysis By Chemical Group Type

5.3. Y-o-Y Growth Projections By Chemical Group Type

5.4. Market Value and Volume Forecast By Chemical Group, 2016–2026

5.4.1. Alcohol

5.4.1.1. Ethanol

5.4.1.2. Isopropanol

5.4.1.3. Propanol

5.4.1.4. Propylene Glycol

5.4.2. Amine

5.4.2.1. Aniline

5.4.2.2. Diphenylamine

5.4.2.3. Methylethanolamine

5.4.2.4. Trimethylamine

5.4.3. Esters

5.4.3.1. Acetyl Acetate (Acetic Anhydride)

5.4.3.2. Ethyl Acetate

5.4.3.3. Butyl Acetate

5.4.4. Ethers

5.4.4.1. Diethyl Ether

5.4.4.2. Anisole

5.4.4.3. Polyethylene Glycol

5.4.5. Chlorinated Solvents

5.4.5.1 Carbon Tetrachloride

5.4.5.2Dichloromethane

5.4.6. Others

5.4.6.1 Chelating Agents

5.4.6.2 Glycerin

5.4.6.3 Acetone

5.5. Prominent Trends

5.6. Market Attractiveness By Chemical Group

6. Global Analysis and Forecasts, By Region

6.1. Basis Point Share (BPS) Analysis By Region

6.2. Y-o-Y Growth Projections By Region

6.3. Market Value and Volume Forecast By Region

6.3.1. North America

6.3.2. Latin America

6.3.3. Western Europe

6.3.4. Eastern Europe

6.3.5. APEJ

6.3.6. Japan

6.3.7. MEA

6.4. Market Attractiveness By Region

7. North America Analysis and Forecast

7.1. Introduction

7.1.1. Basis Point Share (BPS) Analysis By Country

7.1.2. Y-o-Y Growth Projections By Country

7.1.3. Key Regulations

7.2. Market Value and Volume Forecast By Chemical Group, 2016–2026

7.2.1. Alcohol

7.2.2. Amine

7.2.3. Esters

7.2.4. Ethers

7.2.6. Others

7.3. Market Value and Volume Forecast By Country, 2016–2026

7.3.1. US

7.3.2. Canada

7.4. Market Attractiveness Analysis

7.4.1. By Chemical Group

7.4.2. By Country

7.5. Prominent Trends

7.6. Drivers and Restraints: Impact Analysis

8. Latin America Analysis and Forecast

8.1. Introduction

8.1.1. Basis Point Share (BPS) Analysis By Country

8.1.2. Y-o-Y Growth Projections By Country

8.1.3. Key Regulations

8.2. Market Value and Volume Forecast By Chemical Group, 2016–2026

8.2.1. Alcohol

8.2.2. Amine

8.2.3. Esters

8.2.4. Ethers

8.2.5. Chlorinated Solvents

8.2.6. Others

8.3. Market Value and Volume Forecast By Country, 2016–2026

8.3.1. Argentina

8.3.2. Brazil

8.3.3. Mexico

8.3.4. Rest of Latin America

8.4. Market Attractiveness Analysis

8.4.1. By Chemical Group

8.4.2. By Country

8.5. Prominent Trends

8.6. Drivers and Restraints: Impact Analysis

9. Western Europe Analysis and Forecast

9.1. Introduction

9.1.1. Basis Point Share (BPS) Analysis By Country

9.1.2. Y-o-Y Growth Projections By Country

9.1.3. Key Regulations

9.2. Market Value and Volume Forecast By Chemical Group, 2016–2026

9.2.1. Alcohol

9.2.2. Amine

9.2.3. Esters

9.2.4. Ethers

9.2.5. Chlorinated Solvents

9.2.6. Others

9.3. Market Value and Volume Forecast By Country, 2016–2026

9.3.1. UK

9.3.2. France

9.3.3. Germany

9.3.4. Italy

9.3.5. Spain

9.3.6. Nordic

9.3.7. Benelux

9.3.8. Rest of Western Europe

9.4. Market Attractiveness Analysis

9.4.1. By Chemical Group

9.4.2. By Country

9.5. Prominent Trends

9.6. Drivers and Restraints: Impact Analysis

10. Eastern Europe Analysis and Forecast

10.1. Introduction

10.1.1. Basis Point Share (BPS) Analysis By Country

10.1.2. Y-o-Y Growth Projections By Country

10.1.3. Key Regulations

10.2. Market Value and Volume Forecast By Chemical Group, 2016–2026

10.2.1. Alcohol

10.2.2. Amine

10.2.3. Esters

10.2.4. Ethers

10.2.5. Chlorinated Solvents

10.2.6. Others

10.3. Market Value and Volume Forecast By Country, 2016–2026

10.3.1. Russia

10.3.2. Poland

10.3.3. Rest of Eastern Europe

10.4. Market Attractiveness Analysis

10.4.1. By Chemical Group

10.4.2. By Country

10.5. Prominent Trends

10.6. Drivers and Restraints: Impact Analysis



【レポートのキーワード】

製薬用溶剤

★調査レポート[製薬用溶剤の世界市場2016-2026] (コード:FMI703067)販売に関する免責事項を必ずご確認ください。
★調査レポート[製薬用溶剤の世界市場2016-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆